Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site.
about
Antimalarial drug resistance: An overviewEcotope-based entomological surveillance and molecular xenomonitoring of multidrug resistant malaria parasites in anopheles vectorsGenomic analysis of local variation and recent evolution in Plasmodium vivax.Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapyNovel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of VanuatuRole of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.Clinical proteomics of the neglected human malarial parasite Plasmodium vivax.Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries.Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of ChinaDifferent allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from ChinaPlasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaPrevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers.A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New GuineaPhenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central ChinaCurrent opinion on an emergence of drug resistant strains of Plasmodium falciparum through genetic alterations.Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.Anti-folate combination therapies and their effect on the development of drug resistance in Plasmodium vivaxMutations of pvdhfr and pvdhps genes in vivax endemic-malaria areas in Kota Marudu and Kalabakan, SabahFolate metabolism as a source of molecular targets for antimalarials.Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern PakistanRole of Plasmodium vivax Dihydropteroate Synthase Polymorphisms in Sulfa Drug Resistance.Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of Plasmodium vivax from Kolkata, India.Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).Computational analysis of binding between malarial dihydrofolate reductases and anti-folates.Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.Plasmodium vivax trophozoites insensitive to chloroquine.Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported Plasmodium vivax in the State of Qatar.Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern.Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.Plasmodium vivax Biology: Insights Provided by Genomics, Transcriptomics and Proteomics.Presence of novel triple mutations in the pvdhfr from Plasmodium vivax in Mangaluru city area in the southwestern coastal region of India.Simultaneous detection of Plasmodium vivax dhfr, dhps, mdr1 and crt-o resistance-associated mutations in the Colombian Amazonian region.
P2860
Q26753085-84B61A77-B3DB-4FB2-A432-1544247A2B59Q27012441-D7E68AF4-B41F-4134-9113-B851FEE2A7C5Q27149930-23A90101-EC89-4FA1-A138-52CA9058C82FQ28125913-504240EE-F467-432E-BE45-75725BABF3E3Q31143848-FEF0F995-AC5C-4F19-88EF-A31CC40D59B9Q33549954-C478959E-A025-4F7A-9753-225EB32C6423Q33876651-0E9A5A46-99BB-4A45-BBBA-23DC6223637CQ34058745-70ED052E-C97F-4B17-B5AD-8782E23CFC92Q34087282-42A0AF67-F645-4F24-921C-4F60C0171BAFQ34168392-8D4F2C5C-5F5E-45B2-8CAA-5FD199690253Q34341770-25EB6F6D-59F0-4D27-AD7A-2EC826BED099Q34596548-F3916534-D913-45D5-A874-099719ED5446Q34826216-3CB372AC-EECD-4CEA-844C-ECAB1E9668E1Q35179188-CD0441AE-4D0E-43DD-81C1-1C352A549853Q35191546-ABA80E90-7361-4969-B929-DF1C2989BF90Q35338795-0273F8B5-1ECB-4C73-A376-6EC5795D051DQ36144097-D9BCDD3A-29A3-45EE-8B1C-38D1302EA23AQ36232661-478CD6B8-32A8-43D2-A070-E007D1BFCAF9Q36445373-208D37FA-9965-419B-AF61-E45321948064Q36469382-B1F55A30-2C1E-40FC-B0D5-6354C3D89D63Q36498859-558BC2B3-4AB4-42D0-AF14-202BBBFF28F7Q36512482-C82BF4B4-5205-4563-9A40-ED186C4A5F1EQ36549855-DF74FFD6-3116-421A-B1C3-04D232ACCBE2Q36895753-EDAEAC00-283E-4363-9AA3-D617D6D24C7AQ37070636-C9F14009-D544-4EC5-A260-79049EC5DB6FQ37119954-56ABFC6F-22E4-41F8-AADA-B9B17A84ACD0Q37463375-88273B71-118D-489F-B77A-0ED20F718316Q37544364-5BA9F70C-9260-4EB6-A539-DBFA42D5DF28Q37704841-B716EAB6-C4F4-411C-AD01-FD2A5798EBCEQ38945759-38250FD7-89B9-4D24-A7DB-02F4ECC6C78FQ39094085-B7AED8BA-E9B8-46A7-8986-871BC8A13D45Q39245418-BBE863C4-9156-4994-8C5B-54AD97AB574CQ41911774-88CAF714-C19F-4FCB-AD91-BCC5609858ABQ41943390-48FCCC49-DC4C-4B3D-B0D0-24CE5C83FCD5Q41945793-42495E29-C0E0-4E95-B231-89420106EC62Q47995034-3320971F-9451-4DD6-9B48-C71CAF06C026Q50225360-4571AC47-0899-4867-B4EE-2D8DD05E40BBQ52585064-3BF0689B-052B-46FB-8B9D-B757864DD153Q52630325-A1C674ED-43D1-4160-AA2D-AEDFD2404A64
P2860
Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Sulfadoxine resistance in Plas ...... tive sulfadoxine-binding site.
@ast
Sulfadoxine resistance in Plas ...... tive sulfadoxine-binding site.
@en
type
label
Sulfadoxine resistance in Plas ...... tive sulfadoxine-binding site.
@ast
Sulfadoxine resistance in Plas ...... tive sulfadoxine-binding site.
@en
prefLabel
Sulfadoxine resistance in Plas ...... tive sulfadoxine-binding site.
@ast
Sulfadoxine resistance in Plas ...... tive sulfadoxine-binding site.
@en
P2093
P2860
P1476
Sulfadoxine resistance in Plas ...... tive sulfadoxine-binding site.
@en
P2093
Joanne Baker
Karl Rieckmann
Katja Fischer
Michael Korsinczky
Nanhua Chen
P2860
P304
P356
10.1128/AAC.48.6.2214-2222.2004
P407
P577
2004-06-01T00:00:00Z